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Insulin, the most potent anabolic hormone, is critical for somatic
growth and metabolism in vertebrates. Type 2 diabetes, which is the
primary cause of hyperglycemia, results from an inability of insulin to
signal glycolysis and gluconeogenesis. Our previous study showed
that double knockout of insulin receptor a (insra) and b (insrb) caused
-cell hyperplasia and lethality from 5 to 16 days postfertilization
(dpf) (Yang BY, Zhai G, Gong YL, Su JZ, Han D, Yin Z, Xie SQ. Sci
Bull (Beijing) 62: 486–492, 2017). In this study, we characterized the
physiological roles of Insra and Insrb, in somatic growth and fueling
metabolism, respectively. A high-carbohydrate diet was provided for
insulin receptor knockout zebrafish from 60 to 120 dpf to investigate
phenotype inducement and amplification. We observed hyperglyce-
mia in both insra/ fish and insrb/ fish. Impaired growth
hormone signaling, increased visceral adiposity, and fatty liver were
detected in insrb/ fish, which are phenotypes similar to the
lipodystrophy observed in mammals. More importantly, significantly
diminished protein levels of P-PPAR, P-STAT5, and IGF-1 were
also observed in insrb/ fish. In insra/ fish, we observed
increased protein content and decreased lipid content of the whole
body. Taken together, although Insra and Insrb show overlapping
roles in mediating glucose metabolism through the insulin-signaling
pathway, Insrb is more prone to promoting lipid catabolism and
protein synthesis through activation of the growth hormone-signaling
pathway, whereas Insra primarily acts to promote lipid synthesis via
glucose utilization.
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INTRODUCTION
Insulin is well known as the most potent anabolic hormone.
It plays a fundamental role in the regulation of somatic growth
and metabolism of vertebrates (16). The insulin/insr interaction
serves to amplify and diversify insulin action (28, 45). The
major effects of insulin include stimulation of glucose utiliza-
tion and synthesis of glycogen, lipids, and protein (8). Even
mild impairment of insulin secretion may have a great impact
on metabolic homeostasis. Decreased insulin secretion leads to
increased food intake and weight gain (brain), decreased glu-
cose uptake (muscle), decreased inhibition of glucose produc-
tion (liver), and increased lipolysis (adipocytes) (22). How-
ever, there is a gap in our understanding of the precise function
of insulin/insr pathway in the nutritional metabolism of te-
leosts.
The insulin receptor (INSR) belongs to the tyrosine kinase
receptor subfamily, which is expressed at the cell surface as
heterodimers and monomers (37). After binding to insulin, a
conformational change is triggered that enables the receptor to
bind ATP and activate INSR tyrosine kinases (20). Insulin
receptor substrate proteins (IRS) are then phosphorylated as a
critical node, leading to activation of downstream pathways of
two other critical nodes, phosphatidylinositol 3-kinase (PI3K)
and AKT/PKB, which control the metabolic action of insulin and
regulate the expression of genes that mediate cell growth and
differentiation (2, 51).
A thorough systematic study of INSR dysfunction in mice
has been conducted (28). Briefly, depletion of Insr in mice
resulted in only slight growth retardation at birth. After birth,
glucose levels rose to 1,000-fold above normal upon feeding,
which was followed by death from diabetic ketoacidosis (1,
21). Meanwhile, humans lacking INSR showed severe intra-
uterine growth retardation, failure to thrive, fasting hypogly-
cemia, postprandial hyperglycemia, and other insulin-resistant
syndromes (11, 53, 58). The Cre-lox P system has been used to
create a tissue-specific Insr knockout to clarify the role of
Insr-mediated signaling in fueling homeostasis and to measure
physiological effects in a tissue-specific manner (28). The
lethal phenotype of Insr knockout made it difficult for a
comprehensive understanding of insulin receptor function in
tissues of adult mice, whereas the conditional ablation of Insr
in the target tissue only allowed for a partial understanding of
the effects of tissue-specific Insr knockout on whole body
metabolism.
Mammals have two alternative splice variants of exon 11
from the insr gene after activation of insulin in tissues. How-
ever, the zebrafish genome was duplicated during evolution
and there are two insr genes: insra and insrb, which share 68.3
and 65.1% sequence homology with human INSR, respectively
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(54). Furthermore, these two individual zebrafish insr genes are
75.3% identical to each other in their primary sequence (54).
Meanwhile, similar to the expression pattern of human INSRA
and INSRB variants, insra and insrb are also expressed in
insulin-secreting cells in zebrafish (60). Therefore, studying
physiological roles of insulin could benefit from the functional
analysis of Insra and Insrb.
We have established insra- and/or insrb-knockout models in
zebrafish and have evaluated the effects of redundant and
overlapping roles of these receptors during early development
of zebrafish (60). Not surprisingly, a lethal phenotype was
observed in the insra and insrb double knockout zebrafish
before 16 days postfertilization (dpf), which was similar to
results in Insr knockout mouse (1, 21) and humans with INSR
mutations (11, 53, 58). However, despite higher glucose levels
caused by the increased gluconeogenesis and decreased glyco-
lysis in single and double knockout zebrafish at 3–5 dpf, the
insra or insrb knockout zebrafish could survive, grow, and
breed normally when they were fed with Artemia salina.
Therefore, various insr knockout zebrafish lines offered an
unrivaled model to explore the basal functions of insulin/insr
signaling at adult stages.
Many studies of the two receptors in zebrafish embryonic
stages have shown that Insra and Insrb have different, albeit
somewhat overlapping, roles during early development (54).
To further investigate the different roles of Insra and Insrb in
somatic growth and fuel metabolism, we used individual insr
knockout fish and comparatively analyzed the biological func-
tions of each insr under the inducement and amplification of a
high carbohydrate-diet condition (HCD).
MATERIALS AND METHODS
Ethics statement. The experimental fish were obtained from the
Institute of Hydrobiology, Chinese Academy of Sciences (Wuhan,
China). All animal experiments were conducted according to the
Guiding Principles for the Care and Use of Laboratory Animals and
were approved by the Institute of Hydrobiology, Chinese Academy of
Sciences (Approval ID: IHB 2013724).
Establishing insra or insrb knockout lines. The insra or insrb
knockout lines of zebrafish used in this study were described previ-
ously (60). Regions containing restriction enzyme sites for ACCI or
Tsp45I were targeted for knockout in insra/ or insrb/ fish,
respectively. Additionally, identification of the indigestive amplified
fragment of the target region containing ACCI or Tsp45I from
individual tail DNA was used for mutant screening. We established
three genetic zebrafish groups for the experiments: insra/, in-
srb/, and control fish.
Experimental diets. A HCD was formulated and manufactured to
contain 41% carbohydrates (Table 1). The experimental diet was
supplemented with a premix of crystalline L-amino acids according to
the amino acid profile of the dorsal muscles of zebrafish, including
Ala, Arg, Asp, Gly, and Lys (25).
Growth experiment. All male zebrafish were maintained at 28.5°C
with a photoperiod cycle of 14 h of light and 10 h of darkness (59).
The growth trial was conducted in 120-liter aquariums with a recir-
culating system (1 l/min) and biology/mechanical filtration. The three
genetic groups of zebrafish were initially raised with Artemia salina
until 60 dpf. Twenty male fish of each genotype were then randomly
selected and stocked in one aquarium at a mean weight of
0.193 0.002 g. Three replicate aquariums were used in this study.
During the 60-day experiment, fish were fed with a HCD to apparent
satiation three times per day at 0830, 1230, and 1630. We identified
the genotype of each fish at the end of the growth trial. Final fish
weight from each genotype group and survival rate in each aquarium
were then determined. We repeated the entire growth trial with the
same conditions described in this section to measure food intake,
oxygen consumption, and anabolic rate of the fish from the three
genotype groups.
Food intake measurement. After the growth trial, 18 fish of each
genotype were randomly selected and separately allocated into
three aquariums. All fish from nine aquariums (3 aquariums for 1
genotype) were then acclimated for 1 wk under the same conditions
as the above growth experiment. Before the food intake was
measured, fish were starved for 24 h and weighed. Then, fish were
fed to apparent satiation three times a day for 1 wk, and daily food
intake was recorded. Relative food intake (feeding rate) was
calculated as follows: feeding rate (%/day)  100  (food intake/
initial body weight)/days.
Oxygen consumption. After the growth trial, oxygen consumption
of the fish from the three genotype groups was measured as
described previously (34). Briefly, fish were starved for 48 h,
weighed, transferred, and maintained individually in separate res-
piration chambers (n  6 for 1 genotype) with 1 liter of fresh water
at 28°C. Oxygen concentration was measured using a SevenGo
pro-SG6 oximeter (Analytical, CH-8603; Mettler-Toledo; Colum-
bus, OH) after 6 h of enclosure within the chamber. The oxygen
concentration in the respiration chamber without any fish during
the same period was treated as the initial oxygen concentration.
Oxygen consumption was expressed as milligrams per O2 per hour
per gram of body weight.
In vivo anabolic rate assay. After the growth trial, 10 fish of each
genotype were used to perform the anabolic rate assay. The anabolic
assays of intraperitoneally injected L-[14C(U)] amino acid mixture
Table 1. The formulation and composition of the high-
carbohydrate diet
Ingredients Content, %
Casein 33.00
Gelatin 2.00
Dextrin 24.00
Corn starch 24.00
Soybean oil 8.00
Vitamin premix 0.90
Choline chloride 0.10
Mineral premix 1.00
Monocalcium phosphate 2.50
Crystalline amino acid
L-Ala 1.00
L-Arg 1.00
L-Asp 1.00
L-Gly 1.00
L-Lys 0.50
Proximate composition
Moisture, % 13.50
Crude protein, %DM 36.32
Crude fat, %DM 5.50
Carbohydrate, %DM 41.42
Ash, %DM 3.26
Gross energy, kJ/g 20.67
Casien and crystalline amino acid (purity98%) were imported from Sigma
(St. Louis, MO). Gelatin was purchased from Tainjin Bodi Chemical Holding
(Tianjin, China). Vitamin premix (mg/kg diet) contained the following: 100
tocopherol acetate, 25 sodium menadione bisulfate, 6.9 retinyl acetate, 0.05
cholecalciferol, 30 thiamin, 30 riboflavin, 20 pyridoxine, 0.1 cyanocobalamin,
200 nicotinic acid, 15 folic acid, 1,000 ascorbic acid, 500 inositol, 3 biotin, and
100 calcium pantothenate. Mineral premix (mg/kg diet) contained the follow-
ing: 0.65 CoCO3, 9 CuSO4, 8.34 FeSO4·7H2O, 0.5 KI, 22.85 MnSO4·H2O,
0.01 NaSeO3, 14.3 ZnSO4·7H2O, 400 NaCl, 1,860 CaCO3, and 240 MgO, 240.
Carbohydrate [%dry matter (DM)] 100  (crude protein  crude fat 
crude ash).
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(received an injection of 0.025 	Ci/4 	l DMSO per gram of body
weight) or palmitic acid [1-14C] (received an injection of 0.02 	Ci/4
	l DMSO per gram of body weight) were performed in live fish as
previously described (42). Two houre after injection with L-[14C (U)]
amino or [1-14C] palmitic acid, tissues (liver, muscle) and whole body
from each genotype group were sampled. In addition, 2 h after the
injection with [1-14C] palmitic acid, total lipids from each fish
genotype were extracted and weighed. Tissues, whole body and total
lipids from each fish genotype were then digested with HClO4/H2O2
(2:1) at 60°C. The retention of radioactivity from different tissues,
whole body, or total lipids was determined using a Tri-Carb 4910TR
Liquid Scintillation Analyzer (PerkinElmer, Waltham, MA).
Sampling. At the end of the growth trial, eight fish of each genotype
in each aquarium were randomly sampled 1 h after feeding. Fish were
anesthetized in 0.02% ice-cold MS-222 (cat. no. A5040; Sigma, St.
Louis, MO). The caudal fin was severed with scissors, and whole
blood was collected from the wound with heparin-treated tips. Blood
samples from three fish of each genotype in each aquarium were used
for blood glucose measurement. Plasma was then isolated from the
blood of remaining five fish by centrifugation at 4°C (1,500 g for 15
min) and stored at 80°C for later analysis. After blood sampling,
liver, muscle, and pituitary tissues were immediately sampled for
mRNA and protein analysis and visceral mass was sampled for lipid
extraction.
Nile Red staining and Oil Red O staining. Neutral lipid accumu-
lation was visualized using fluorescent dye staining in live fish. One
fish of each genotype in each aquarium (3 fish per genotype) was
sampled for Nile Red staining. Nile Red (N3013; Sigma) was dis-
solved to a concentration of 0.1 	g/ml. Both mutant and control fish
were immersed at 28°C overnight in the dark. Images were obtained
using an Olympus SZX16 FL stereomicroscope (Olympus, Tokyo,
Japan) at an excitation wavelength of 488 nm. The liver of one fish of
each genotype in each aquarium (3 fish per genotype) was initially
fixed in 4% paraformaldehyde and then sectioned with a cryostat.
Frozen sections were stained with Oil Red O to visualize fatty droplet
accumulation in the liver.
Biochemical analyses. Blood glucose levels were measured using a
blood glucose monitor (Accu-Chek Performa; Roche, Basel, Switzer-
land). Plasma and liver triglycerides (TGs) were measured using a
Triglyceride Colorimetric Assay Kit (Cayman Chemical, Ann Arbor,
MI) according to the manufacturer’s instructions. Plasma cholesterol,
nonesterified fatty acids (NEFAs), and phospholipids were measured
using LabAssay cholesterol, NEFA, and phospholipid kits (Wako
Pure Chemical Industries, Tokyo, Japan), respectively.
Proximate compositions were determined according to the methods
described by the Association Official Analytical Chemists (18). Eight
zebrafish of each genotype per aquarium were randomly selected,
frozen in liquid nitrogen for 3 h, and stored at 80°C for 24 h. The
eight fish were then mixed as one sample and ground into a powder
after they were freeze dried (Alpha 1–4 LD plus; Martin Christ,
Osterode, Germany) for 24 h. Crude protein content (N 6.25) was
determined by the Kjeldahl method after acid digestion using a 2300
Kjeltec Analyzer Unit (FOSS Tecator, Haganas, Sweden). Crude lipid
content was determined by ether extraction in a Soxtec system (Soxtec
System HT6; Tecator). Crude ash content was determined by incin-
eration in a muffle furnace at 550°C for 12 h. Moisture content was
determined by oven drying at 105°C until samples reached a constant
weight. Visceral mass lipid content was determined following homog-
enization in chloroform/methanol (2:1, vol/vol) according to the
method described by Folch et al. (12).
Quantitative real-time PCR. Total RNA was extracted from liver
and adipose tissue samples using TRIzol reagent and cDNA was
synthesized using an oligo (dT) 18 primer and the Revert Aid
First-Strand cDNA Synthesis Kit (K1622; Thermo Scientific,
Waltham, MA) according to manufacturer’s instructions. Quantitative
(q)PCR primers were designed using the National Center for Biotech-
nology Information primer BLAST service and are listed in Table 2.
All mRNA levels were calculated as fold expression relative to the
housekeeping gene, GAPDH. All samples were run in triplicate, and
the results are expressed according to the method described by Bustin
et al. (4).
Western blot analysis. Total hepatic, pituitary and muscle proteins
were extracted using a protein extraction buffer (Thermo Scientific)
according to the manufacturer’s instructions. Equal amounts of pro-
tein were subjected to SDS-PAGE and transferred to PVDF mem-
branes. The PVDF membranes were blocked with 5% milk in TBS
Tween and then incubated with anti-GCK (HPA007093; Sigma),
anti-AKT [9272S; Cell Signaling Technology (CST), Danvers, MA],
anti-AMPK (2532S; CST), anti-insulin grwoth factor-1 (anti-IGF-1;
ab9572; Abcam, Cambridge, UK), anti-phospho-AKTs473 (4060S; CST),
anti-phospho-AMPKThr172 (2535S; CST), anti-phospho-S6ser240/244
(2215S; CST), anti-phospho-STAT5A/BTyr694/699 (2189940; Millipore,
Billerica, MA), anti-phospho-PPARs12 (ab3484; Abcam), anti-GH1 (a
gift from Dr. Wei Hu, Institute of Hydrobiology, Chinese Academy of
Sciences), and anti-GAPDH (ab70699; Abcam) antibodies. The anti-
bodies were used at a 1:1,000 dilution. Horseradish peroxidase-
labeled secondary antibodies were used to generate a chemilumines-
cent signal that was detected with a CCD camera-based imager
(Chemidoc MP Imaging System; Bio-Rad). GAPDH served as a
control. All samples were repeated three times.
Statistical analysis. Data were analyzed with GraphPad Prism 5.0.
All results are presented as means SE. Differences were assessed
using a one-way ANOVA. For all statistical comparisons, P 
 0.05
was used to indicate a statistically significant difference.
RESULTS
Blood glucose and glucose metabolism. Compared with
control siblings, insra/ fish and insrb/ fish showed
higher blood glucose levels than control fish at 1 h postprandial
(Fig. 1A). This outcome was consistent with the measurement
of total glucose in insra/, insrb/, and control fish at the
larval stage (60). It was worth noting that the glucose level in
insra/ fish was higher than that in insrb/ fish, which
suggested a more critical role of Insra than Insrb in glucose
metabolism. As observed in the Western blot analysis, the
amount of GCK protein, involved in glycolysis (43), was
significantly decreased in insra/ fish and insrb/ fish
compared with the control fish, with insra/ fish showing
the greatest decrease in protein levels (Fig. 1, B and C).
We subsequently explored the expression of genes involved
in glycolysis using real-time qPCR. These genes included
hexokinase domain containing 1 (hkdc1), glucokinase (gck);
aldolase a (aldoaa); pyruvate kinase, liver, and RBC (pklr);
and glucose-6-phosphate isomerase a (gpia) (Fig. 1D). The
results demonstrated that the transcripts involved in glycolysis,
hkdc1, gck, aldoaa, pklr, and gpia were decreased in both
insra/ and insrb/ fish, which suggested that glycolysis
was downregulated when the insr was depleted. These results
indicated that both insra and insrb played pivotal roles in
glycolysis and they partially explained why insra/ fish
showed higher levels of blood glucose than insrb/ fish or
control fish. The glucose-6-phosphatase a, catalytic subunit,
tandem duplicate 1 (g6pca.1) gene, involved in gluconeogen-
esis, was significantly downregulated in both insra/ and
insrb/ fish (Fig. 1D).
A previous study indicated that the insulin-signaling path-
way regulated glucose homeostasis through the downstream
AKT-signaling cascade (6, 24, 62). Thus we examined the
levels of total AKT (T-AKT) and phosphorylated AKT (P-
AKT) protein. As expected, P-AKT levels in insra/ fish
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and insrb/ fish were lower compared with control fish. It is
worth noting that P-AKT levels were higher in insra/ fish
compared with insrb/ fish (Fig. 1, E and F), which was
likely due to the increased expression of insulin-like growth
factor 1 (igf1) and insulin-like growth factor 1 receptor (igf1r)
in insra/ fish (see below). This may also activate the
AKT-signaling pathway (57, 63).
Body weight, food intake, and oxygen consumption. To
investigate the individual physiological function of insra and
insrab in insulin-signaling pathways, an HCD was provided to
amplify the redundant and overlapping roles of each receptor in
fueling homeostasis. After 60 days of being fed with Artemia
salina, growth performance and biochemical analysis were
conducted (Table 3). Out of insra/, insrb/, and control
fish, only insrb/ fish demonstrated decreased protein but
increased lipid content. However, the divergence of body
composition could not be observed visually. After the 60-day
HCD growth trial, the body weight of control and knockout
fish markedly diverged, with both insra/ fish and insrb/
fish demonstrating significant increases in body weight com-
pared with control fish (Table 4). The increased body weight
gain in insra/ fish and insrb/ fish compared with
control fish led us to further measure food intake of the fish
from the three genotype groups. As expected, insra/ fish
and insrb/ fish had significantly higher feeding rates than
control fish (Fig. 2A). To assess energy expenditure, we tested
oxygen consumption rate and found that there was no signifi-
cant difference in oxygen consumption between mutants and
control fish (Fig. 2B).
AMPK signaling has a close relationship with the metabo-
lism and energy requirements of organisms. To explore ana-
bolic levels, we examined AMPK protein. A significant de-
crease in phosphorylated AMPK (P-AMPK) was observed in
insra/ or insrb/ fish (Fig. 2, C and D). As it is a cellular
energy sensor responding to low ATP levels (38), decreased
P-AMPK seen here suggests that catabolic pathways, such as
the biolysis of lipids and proteins that generate ATP, may be
switched off (35). The increased body weight in insra/ or
insrb/ fish may be tightly linked to AMPK-signaling inhi-
bition.
Table 2. Primer sequences used for quantitative real-time PCR
Gene Accession No. Forward Primer (5=–3=) Reverse Primer (5=–3=) Product Size (bp)
Insulin signaling pathway-related genes
pik3cd NM_201199.1 CTGTCTGGCATCTGTCCTGC TTCAGTGCATCGTGTCGCAA 186
pik3ca XM_009306177.2 CGTTCATGCACTGTTCGCTA TGGGACAGCCATATGGTACAC 243
ppp1caa NM_214811.2 CCCTGTTCTCCGCTCCTAAC GAGGGTGGTGGGAGTCCAT 232
ppp1r3da NM_001110412.2 CTGCACAGAGTTTGTGTCGC CCCACCAGGAGAATCCGATG 112
pde3b XM_686791.8 GTGAGAGGACCCTTTGGTGG TGGCACCATTATCCCGTCTG 116
prkag2a NM_001077179.2 ACTTCCACCTCCGTGATTCG GACAGAGTGGAGCTCAGACG 178
irs2a NM_200315.1 GCTCAGATGGAAAAGCTGCG TTGGCCTCTTCGGCTTGATT 226
mknk2b NM_194402.1 CGGGGTTTCCCGTTAAAAGC TTATTTGGACTGGCGGCAAC 104
shc2 NM_001044973.1 GACCAGGGTGGAGGGAATA GAGATGTTGACGCCGATG 342
socs2 NM_001114550.1 AAGGCAGGACTAACCAAATCG TTGATGGCAATACGGCACAGG 112
socs1a NM_001003467.1 GCCTGCTCTTGGAGTACTTG CCTGGATCTTTGGGATTGGAA 205
Glycolysis-related genes
hkdc1 NM_001115125.1 CATCCTTTCAGAGGACGGCA CCAAGAACCACCGCTTCAAC 223
gck NM_001045385.2 CACCGCTGACCTGCTATGAT AGTCGGCCACTTCACATACG 102
aldoaa NM_194377.2 AGGCTGATCCGTGAGTGTTG GCCACGCTACCTGTAGACTC 188
pklr NM_201289.1 TCCTGGAGCATCTGTGTCTG GTCTGGCGATGTTCATTCCT 144
gpia NM_144763.1 ACTGTACGGTCGTGTTTCCC ATGTTGAGGTTTCCCACGCT 131
Gluconeogenesis-related gene
g6pca.1 NM_001003512.2 GCTGCACCATACGAGATGGA TCACCAAACAGCACCCACTT 248
Protein synthesis-related genes
igf1 NM_131825.2 TCGTCCCCACTCTTGTAAAGC TGGCGATGGAGCTTGAACAT 116
igf1rb NM_152969.1 GCCTCAGAGCTGGAGAACTTC CGTTGTTGCGGAAATCTCTTTC 331
ulk2 XM_002664615.4 AGAACACAAGCCGAAGGGAT ATTCCTCCTAACCGCGTGAC 249
mat2aa NM_001290080.1 CTTCCCGTGAAATGTAGGCAG TAAAAACAACATGGCCTGCGG 184
stat1b NM_200091.2 ACGTCCACGTTGAAAGGTAA AGCTGCTTTACGTGGCATTTC 104
bcat1 NM_200064.1 AGGAGACTGCAAGATGGGAGG TGCCGACTGGACTGACAACAC 371
4ebp1 NM_199645.1 GTTGTGCCTGAAAGAGCCAC AAACAAAGTGTGGCATGGCG 116
Lipolysis-related genes
acsl1b NM_001003569.2 CTGACGAGTTCGGTCGAGTT TGGCGTACCAGTATGCAGTG 177
cpt1b NM_001328192.1 TGAGACGGATTCTTTCCGCT TTCGCTAGGCTTGTTACTTGC 242
cpt2 NM_001007447.1 AATGGATTGGGTGCAACGTG TGAGTTCTAACCTTCAGGCTCT 240
lipca NM_201022.1 GGACCGCAGCTTACTTTTGG TCCGACTGGATGTGAAAGTGT 191
fabp1a NM_001044712.1 TCGTTCTGCTTGAACATGCG GCTGTCTCACCATGAAGCAAC 162
Lipogenesis-related genes
fas DQ812117.1 TCCAAGAGTTCAAACACGGT TGAGTGACACCACAACAG 196
foxo1a NM_001077257.2 AGCCTGTCTGAAATGGCTGG TGCTGGCTTACTGCCGATAG 212
fads2 NM_131645.2 CCAATCAGAGCGAGCCTTCA ACGCATTCAAAGTGCCACAA 136
elovl5 NM_200453.2 TTTCGGCTAGAAGGAAAGCAGT GAACCGAAAGTGGGAGGTG 201
acc NM_001271308.1 ATGGCAGAGCAAGACTCCAC CCTCTGCAGGTCGATACGTC 294
ppar DQ017619 AGCGACAATGCTCCTTTT CACTTCGATGACCCCGTA 270
Reference gene
gapdh NM_001115114.1 GTCCACTGACTTCAATGGGGA CCAGATGGGAGAATGGTCGC 217
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HCD results in lipid accumulation to hepatic steatosis in
insrb/ fish. After the analysis of growth performance, we
carried out body composition analysis. We observed that crude
protein content in the insrb/ group was decreased com-
pared with the insra/ and control fish, whereas crude lipid,
carcass lipid, and visceral mass lipid content were significantly
higher in the insrb/ group compared with the insra/
and control fish (Table 4).
Since abdominal adiposity accumulation in insrb/ ze-
brafish was more significant compared with insra/ and
control fish, analysis of neutral lipids with Nile Red staining
was carried out in the three groups. As expected, the Nile Red
fluorescence significantly increased in visceral adipose tissue
in insrb/ fish compared with insra/ and control fish
after 60 days of HCD feeding (Fig. 3, A–C). These results were
similar to the body composition results, i.e., the highest content
of crude lipid, especially visceral mass lipid in insrb/ fish.
Adipocytes activate lipolysis and the breakdown of TGs into
free fatty acids, which are transferred into liver mitochondria to
undergo -oxidation for generating ATP for the organisms
(44). Since the liver is a central organ that is implicated in lipid
metabolism and homeostasis, the pathological features of the
liver were examined with Oil Red O staining. Increased lipid
accumulation and hepatic steatosis were observed in the liver
in insrb/ fish compared with insra/ and control fish
(Fig. 3, D–F). We also quantified fat droplets in the liver and
observed that, although the number of fat droplets were de-
creased in insrb/ fish livers, the average area and frequency
distribution of fat droplets significantly increased compared
with the control fish (Fig. 3, G–I). We also examined adipose
tissue morphology in visceral organs and found that the distri-
bution of adiposity significantly increased in insrb/ fish
(Fig. 3, J–L). All these results suggest that depletion of insrb
leads to accumulated adiposity and compromised hepatic ste-
atosis. In all, insra or insrb knockout fish exhibited different
effects on lipid and protein metabolism.
We subsequently performed biochemical measurements to
examine the quantities of plasma and liver TG, plasma NEFA,
plasma cholesterol, and plasma phospholipid in the three
groups. Plasma and hepatic TG levels in the insrb/ groups
were significantly higher compared with the other two groups
(Fig. 4, A and B). Meanwhile, in the plasma of insrb/ fish,
NEFA, cholesterol, and phospholipids were also increased
compared with insra/ fish and control fish (Fig. 4, C–E). It
was also worth noting that these indices were significantly
decreased in insra/ fish compared with control fish. Taken
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Fig. 1. Analyses of glucose metabolism in insra/ or insrb/ fish. A: blood glucose levels in insra/ fish, insrb/ fish, and control fish (n  5 for each
genotype). B: GCK protein levels in liver samples of insra/ fish, insrb/ fish, and control fish (n  3 for each genotype per time). C: quantification of
relative GCK protein levels from the Western blot are shown in B. D: the expression levels of hkdc1, gck, aldoaa, pklr, gpia, and g6pca.1 in liver samples of
insra/ fish and insrb/ fish were significantly affected compared with control fish (n  3 for each genotype per time). E: phosphorylated (P)-AKT and
total (T)-AKT protein levels in liver samples of insra/, insrb/, and control fish (n  3 for each genotype per time). F: quantification of relative protein
levels of P-AKT from the Western blot are shown in E. The letters x, y, and z in the bar chart represent significant differences of each index in insra/ fish,
insrb/ fish, and control fish (P 
 0.05). The green arrows indicate downregulated levels of the nominated proteins. All protein and mRNA measurements
were repeated 3 times independently.
Table 3. The initial whole body proximate composition of
insra/, insrb/, and control zebrafish before the
feeding trial
Genotype
Whole body composition insra/ insrb/ Control
Moisture, % 70.23  0.00y 67.47  0.01x 69.43  0.00y
Crude protein, %DM 47.52  0.16y 45.63  0.62x 51.80  0.10y
Crude lipid, %DM 32.55  0.08y 37.24  0.75z 30.88  0.09x
Ash, %DM 8.34 9.04 8.49
Values are means  SE of 3 replicate groups (n  3). Labeled means in a
row without a common letter are different, P 
 0.05. Values for whole
composition were obtained from composite samples per replicate group (n 
3). For ash, 3 fish from each genotype were mixed as one sample. DM, dry
matter. x,y,zP 
 0.05, significant differences of each index in insra/ fish.,
insrb/ fish, and control fish.
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together, our results suggested that lipid synthesis in insra/
fish and lipid utilization in insrb/ fish were affected com-
pared with the control fish.
Insrb is involved in protein synthesis via regulating growth
hormone sensitivity. Since insrb/ fish exhibited accumu-
lated visceral adipocyte and total lipid content, but decreased
protein content, we hypothesized that the pathway that pro-
motes lipid utilization and protein synthesis may be impaired
with depletion of insrb. We examined the growth hormone
(GH)-signaling pathway, in which mitochondrial fatty acid
-oxidation and protein synthesis were promoted (26, 33, 39).
In contrast to control fish, insrb/ fish showed diminished
phosphorylation levels of Stat5 (P-STAT5) in muscle (Fig. 5,
A–C), which suggested that lipid accumulation may be result
from a compromised GH-signaling pathway (7, 27, 29). Addi-
tionally, previous studies have indicated that protein synthesis
induced by growth hormone requires signaling through mam-
malian target of rapamycin and GH treatment can enhance the
phosphorylation of ribosomal protein S6 (P-S6) (15). Thus we
subsequently examined the levels of P-S6 in muscles, where
GH exerted direct effects. P-S6 was also diminished in in-
srb/ fish (Fig. 5, A–C). IGF-1 is a prominent mediator of
the effects of GH on skeletal growth (9, 34). IGF-1 was also
decreased in the insrb/ fish liver (Fig. 5, D–F). For lipid
utilization, we examined the levels of P-PPAR in the liver.
Again, insrb/ fish showed diminished P-PPAR in the
liver (Fig. 5, D–F). Combined with a previous study showing
that the insulin increased PPAR phosphorylation and en-
hanced transcriptional activity of PPAR (47), we proposed
that insulin promoted phosphorylation of PPAR via Insrb.
The amount of pituitary GH protein dramatically increased,
which indicated that, although the mechanism was unknown,
insrb deficiency led to GH resistance (Fig. 5, G and H). All
these results suggested that the effects of GH on protein
synthesis and lipolysis were impaired in the absence of Insrb.
We then assessed transcriptional levels of some key ele-
ments involved in the insulin-signaling pathway in the liver to
investigate the effects of each insulin receptor on the insulin-
signaling pathway (Fig. 6A). With the exception of shc2,
socs1a, and socs2, we found that most of the insulin-signaling
pathway genes were significantly downregulated in insrb/
fish compared with control fish. Downregulated genes included
phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic sub-
unit delta (pik3cd); phosphatidylinositol-4,5-bisphosphate
3-kinase catalytic subunit alpha (pik3ca); protein phosphatase
1 catalytic subunit alpha isozyme a (ppp1caa); phosphodies-
terase 3B (ped3b); protein kinase, AMP-activated, gamma 2
Table 4. Growth performance, body condition indexes and
whole body proximate composition of insra/, insrb/,
and control zebrafish fed with the high-carbohydrate diet for
8 wk
Genotype
Variables insra/ insrb/ Control
Initial body weight, g 0.195  0.00 0.191 0.00 0.195  0.00
Final body weight, g 0.365  0.01y 0.343  0.01y 0.311  0.00x
Relative weight gain, % 83.94  3.14y 80.27  6.52y 59.50  1.44x
Initial body length, mm 28.67  0.56 28.5 0.34 29.17  0.31
Final body length, mm 33.06  0.36 32.67 0.27 32.44  0.25
Survival, % 98.33 1.67 96.67 1.67 98.33  1.67
Condition factor, g/cm3 1.45  0.03xy 1.48  0.05y 1.33  0.01x
Whole body composition
Moisture, % 69.23 0.00y 66.47  0.00x 68.43  0.00y
Crude protein, %DM 50.79 0.66y 46.68  1.25x 49.18  0.85xy
Carcass protein content,
%DM 52.54 0.26xy 51.41  0.39x 53.33  0.23y
Crude lipid, %DM 26.66 0.39x 36.52  0.55z 29.16  0.32y
Carcass lipid content,
%DM 25.31 0.42x 26.66  0.16y 24.95  0.26x
Visceral mass lipid, %DM 55.33 0.04x 63.28  0.06x 58.05  0.03y
Ash, %DM 9.88 10.44 9.99
Values of means of 3 replicate groups (n  3). Labeled means in a row
without a common letter are different, P 
 0.05. Condition factors (g/cm3) 
(body weight 100)/(body length3). Values for whole body composition were
obtained from composite samples per replicate group (n  3). For ash, 3 fish
from each genotype were mixed as 1 sample. DM, dry matter. x,y,zP 
 0.05,
significant differences of each index in insra/ fish, insrb/ fish, and
control fish.
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Fig. 2. Measurements of feeding rate and oxygen
consumption. A: measurement of food intake rate in
zebrafish of 3 genotypes (n  18 for each genotype,
divided into 3 groups). B: measurement of oxygen
consumption rate in zebrafish of 3 genotypes (n  18
for each genotype, divided into 3 groups). C: phos-
phorylated (P)-AMPK and total (T)-AMPK levels in
liver samples of insra/, insrb/, and control
fish (n  3 for each genotype per time). D: quanti-
fication of P-AMPK relative protein levels from the
Western blot are shown in C. The letters x, y, and z
in the bar chart represent significant differences of
each index in insra/ fish, insrb/ fish and
control fish (P 
 0.05). N.S., no significance. The
green arrows indicate downregulated levels of the
nominated proteins. All protein measurements were
repeated 3 times independently.
E43THE PHYSIOLOGICAL ROLES OF INSULIN RECEPTORS IN ZEBRAFISH
AJP-Endocrinol Metab • doi:10.1152/ajpendo.00227.2017 • www.ajpendo.org
Downloaded from www.physiology.org/journal/ajpendo (159.226.163.014) on July 8, 2019.
noncatalytic subunit a (prkag2a); inulin receptor substrate 2a
(irs2a); MAP kinase interacting serine/threonine kinase 2b
(mknk2b); and protein phosphatase 1 regulatory subunit 3Da
(ppp1r3da). However, compared with control fish, insra/
fish exhibited a slight influence on the insulin-signaling path-
way. Compared with the control fish, there was a significant
increase in expression of the suppressor of GH signaling, shc2,
socs1a, and socs2 (7), indicating that IGF-1/IGF-1 receptor
signaling was overactivated when insra was depleted.
Furthermore, the relative gene expression levels of igf1 and
its receptor, igf1r, were significantly higher in insra/ fish
than the other two groups. Genes involved in protein synthesis,
such as unc-51-like autophagy activating kinase 2 (ulk2),
methionine adenosyl-transferase II alpha a (mat2aa), signal
transducer and activator of transcription 1b (stat1b), branched
chain amino-acid transaminase 1, cytosolic (bcat1), and eu-
karyotic translation initiation factor 4E-binding protein (4ebp)
were also increased in the absence of Insra (Fig. 6B). These
observations indicate that protein synthesis is activated via the
insulin/insrb pathway under HCD. All these results suggest
that Insrb is involved in lipid utilization and protein synthesis
by mediating the sensitivity of the GH-signaling pathway.
Changes in mRNA levels of enzymes involved in lipolysis,
mobilization and fatty acid -oxidation, such as cyl-CoA
synthetase long-chain family member 1b (acsl1b), carnitine
palmitoyltransferase 1B (cpt1b), carnitine palmitoyltrans-
ferase 2 (cpt2), lipase alpha (lipca), and fatty acid binding
protein (fabp) were significantly increased in insrb/ fish
liver (Fig. 6C). These may be compensatory effects due to dual
effects of failure of PPAR activation and GH-signaling path-
way deficiency.
Insra is involved in lipid synthesis. During the biochemical
measurements, we also observed that insra/ fish had the
lowest levels of plasma and hepatic TG, plasma NEFA, and
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Fig. 3. Observations of neutral adipose tissues and liver fatty droplets. A–C: Nile Red fluorescence staining of adult zebrafish (n  3 for each genotype). Lateral
view anterior is to the left. White arrowheads: visceral adipose tissue. D–F: Oil Red O staining of adult zebrafish liver sections (n  3 for each genotype) for
insra/ fish (D), insrb/ fish (E), and control fish (F). G–I: quantification of the fat droplets number, the average area of fat droplets, and the frequency
distribution of fat droplets in 3 samples of each genotype. The statistical analysis of the number, average area, and frequency distribution of fat droplets in G–I
is calculated per analyzed area. J–L: cross sections through trunks of adult mutants and their controls show excessive visceral adipose tissue in the insrb/
fish (n  3 for each genotype). The letters x, y, and z in the bar chart represent significant differences of each index in insra/ fish, insrb/ fish, and control
fish (P 
 0.05). Red arrow indicates visceral adipose tissue.
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plasma phospholipids (Fig. 4, A–C, and E). Together with
increased blood glucose levels and decreased visceral and
whole body lipid content in insra/ fish compared with
control fish, we hypothesized that Insra may be responsible for
lipid synthesis from glucose. Consistent with the relative ex-
pression levels of the genes involved in protein synthesis in
insra/ fish, we also observed increased levels of proteins
involved in protein synthesis in muscle, P-S6 and P-STAT5, as
well as increased IGF-1 and P-PPAR in the liver in insra/
fish (Fig. 5, A and B). This outcome explains the composition
measurement results in insra/ fish (Table 4), i.e., increased
protein gain and decreased lipid content. These results sug-
gested that, when insra was depleted, the transition from
glucose to lipid was compromised, while protein synthesis was
activated and growth was facilitated via the insulin/insrb path-
way under HCD.
Expression of lipogenesis enzymes, fatty acid synthase (fas),
fatty acid desaturase 2 (fads2), fatty acid elongase 5 (elovl5),
acetyl-CoA carboxylase alpha (acc), and forkhead box protein
O1 (foxo1a) was assayed by real-time qPCR. Uniformly, fas,
fads2, elovl5, and acc all showed the greatest decrease in
insra/ fish (Fig. 6C). Downregulated expression of genes
involved in lipogenesis was observed in insra/ fish, which
suggests that impaired lipid synthesis occurs by failure to
activate the expression of key enzymes involved in lipogenesis.
However, the downregulation of these genes involved in lipo-
genesis was not observed in insrb/ fish, except for the key
molecule that inhibits lipogenesis but promotes lipolysis,
foxo1a (41). To better elucidate the role of Insra in lipid
synthesis, the expression of fas and ppar, which are essential
in lipid synthesis (30), was quantified in adipose tissue. Sig-
nificantly, fas and ppar expression were significantly dimin-
ished in insra/ fish (Fig. 6D). Combined with the failure of
glucose utilization in insra/ fish, we conclude that Insra is
implicated in lipid synthesis from glucose, while the accumu-
lation of lipids in insrb/ fish may be due to failure of lipid
catabolism, which is reflected through the downregulation of
P-PPAR and foxo1a and GH-signaling pathway deficiency in
the liver of insrb/ fish.
Protein and lipid synthesis. To further confirm the role of
Insra or Insrb in the regulation of protein synthesis or lipid
synthesis directly, we performed an anabolic assay in vivo by
testing the retention of radioactivity 2 h after intraperitoneal
injection with L-[14 C(U)] amino acid mixture or palmitic acid
[1-14C]. The retention of the amino acid mixture in insra/
fish was slightly high in muscle and in the whole body (P 
0.05) compared with control fish (Fig. 7, A–C). The retention
of fatty acids in muscle and liver and the whole body and total
lipid of insrb/ fish were significantly higher (P 
 0.05)
than the other two groups (Fig. 7, D–G). These results directly
indicated that lipid synthesis is promoted when insrb is de-
pleted.
DISCUSSION
In the present study, we observed an interesting phenotype
where weight gain in insra or insrb knockout zebrafish mark-
edly increased compared with that in control fish fed a HCD.
Body weight is considered to be tightly linked to metabolic
pathways. When insra or insrb is deleted, insulin action is
compromised in various physiological processes, especially
those for glucose utilization. In our study, insulin signaling was
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Fig. 4. Measurement of triglyceride (TG), nonesterified fatty acid (NEFA), cholesterol, and phospholipid. A: bar charts represent the quantification and statistical
analyses of plasma TG levels. B: bar charts represent the quantification and statistical analyses of hepatic TG levels. C: bar charts represent the quantification
and statistical analyses of plasma NEFA levels. D: bar charts represent the quantification and statistical analyses of plasma cholesterol levels. E: bar charts
represent the quantification and statistical analyses of plasma phospholipid levels. The letters x, y, and z in the bar chart represent significant differences of each
index in insra/ fish, insrb/ fish, and control fish (P 
 0.05); n  3 for each genotype.
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decreased significantly in insra/ fish and insrb/ fish, as
proven by P-AKT and GCK protein levels and expression of
hkdc, gck, aldoaa, and pklr (Fig. 1). In humans, impaired
insulin action results in decreased insulin signaling in the
hypothalamus, leading to increased food intake and weight
gain (22). In the current study, food intake by insra/ fish
and insrb/ fish was significantly higher than that of control
fish. However, oxygen consumption in these two knockout
genotypes was not changed compared with control fish. The
increased food intake and unchanged oxygen consumption
implied that more energy was retained in their bodies, leading
to an increase in body weight in the mutants. In addition,
AMPK is generally accepted as a crucial cellular energy sensor
in maintaining energy homeostasis (35). When AMPK is
inactivated, it switches off catabolic pathways that generate
ATP but switches on biosynthetic pathways, such as biosyn-
thesis of lipids, carbohydrates, and proteins that consume ATP
(14). Meanwhile, it has been reported that a high glucose
concentration can inhibit AMPK (56). In our study, insra/
fish and insrb/ fish exhibited a one- to twofold increase in
prandial blood glucose level compared with control fish, which
could inhibit AMPK signaling (Fig. 2). As a result, the in-
creased food intake and activated biosynthetic process caused
by decreased phosphorylation levels of AMPK in mutants
actually led to increased body weight compared with the
control siblings.
The liver plays a central role in maintaining body energy
metabolism, while adipose tissue is responsible for energy
storage (7). When lipids in the body exceed the amount the
liver can handle, fat accumulates in the liver (31). In mammals,
hepatic triacylglycerol is associated with insulin resistance. In
obesity, some adipocyte-derived factors and products of mac-
rophages are increased, resulting in insulin resistance by re-
ducing PI3K signaling in muscles (22, 61). It has been pro-
posed that increased NEFA levels and decreased intracellular
content of fatty acids attenuate insulin/insr signaling (48, 49).
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Fig. 5. Western blot analysis. A: P-STAT5 and P-S6 protein content in muscle samples of insra/, insrb/, and control fish. B and C: quantification of
relative P-STAT5 and P-S6 protein levels from the Western blot are shown in A. D: insulin-like growth factor-1 (IGF-1) and P-PPAR protein content in liver
samples of insra/, insrb/, and control fish. E and F: quantification of relative IGF-1 and P-PPAR protein levels from the Western blot are shown in D.
G: growth hormone (GH) protein content in pituitary samples of insra/, insrb/, and control fish. H: quantification of relative GH protein level from the
Western blot are shown in G. n  3 for each genotype per time. All protein measurements were repeated 3 times independently. The letters x, y, and z in the
bar chart represent significant differences of each index in insra/ fish, insrb/ fish, and control fish (P 
 0.05). Red and green arrows indicate the
upregulation and downregulation of proteins, respectively.
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Fig. 6. Real-time quantitative PCR analysis of genes involved in the insulin signaling pathway, protein synthesis, lipid catabolism, and lipid synthesis. A:
expression levels of pik3cd, pik3ca, ppp1caa, pde3b, prkag2a, irs2a, mknk2b, ppp1r3da, pygmb, shc2, socs1a, and socs2 in liver samples of insrb/
significantly decreased compared with control fish and insra/ fish. B: expression levels of igf1, igf1rb, ulk2, mat2aa, stat1b, bcat1, and 4ebp1 in muscle
samples of insra/ fish significantly increased compared with control fish and insrb/ fish. C: expression levels of acs1b, cpt1b, cpt2, lipca, and fabp1a
in liver samples of insrb/ fish significantly increased compared with control fish. D: expression levels of fas, pparr, fads2, elove5, acc, and foxo1a in liver
samples, and fas and pparr in adipose samples of insra/ fish significantly affected compared with control fish. All mRNA measurements were repeated 3
times independently. The letters x, y, and z in the bar chart represent significant differences of each index in insra/ fish, insrb/ fish, and control fish (P 

0.05); n  3 for each genotype per time.
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This is consistent with the plasma lipid features observed in the
insrb-deficiency group, which demonstrated increased NEFA,
cholesterol, triglycerides, and phospholipids (Fig. 4). As de-
scribed in a prior review (40, 55), insulin resistance may
enhance hepatic fat accumulation by increasing free fatty acid
delivery and inducing hyperinsulinemia to stimulate anabolic
processes. Similarly, insrb/ fish exhibited increased fatty
acid delivery, as shown by upregulated expression of fatty acid
binding protein (fabp1a) (Fig. 6). The diminished activation of
P-PPAR and compromised GH-signaling pathway in in-
srb/ fish livers, suggested that impaired hepatic triglycer-
ides catabolism accounted for the fatty liver (Fig. 5). Further-
more, with no more than a 2% increase in carcass lipid content
in insrb/ fish, the fat in the current model of insrb/ fish
showed a specific increase in visceral tissues, without signifi-
cant alterations in peripheral tissues (Fig. 3 and Table 4).
In mammals, GH/IGF-1 signaling regulates skeletal muscle
growth (46). To test the status of GH/IGF-1 signaling in
insra-deficient fish, the expression levels of igf-1 and igf-1r
and protein levels of IGF-1, P-STAT5, and P-S6 were exam-
ined. These results (Figs. 5 and 6), along with the increased
level of overall crude body protein, suggest that GH/IGF-1
signaling is highly activated in insra/ fish. This is also
evidenced by upregulated shc2, socs1a, and socs2 in the
insulin-signaling pathway compared with the control fish. A
decreased amount of visceral adipose tissue was observed in
insra/ fish (Table 4), which contrasted with the increased
adipose tissue in gh mutant fish (36). This was also validated
by the result that insra/ fish had the lowest levels of plasma
and hepatic TG, plasma NEFA, and plasma phospholipids (Fig.
4). This outcome is consistent with the composition measure-
ments in insra/ fish (Table 4), i.e., increased protein con-
tent and decreased lipid content. Combined with slightly higher
retention of an amino acid mixture in muscle and whole body
of insra/ fish than control fish (Fig. 7, A–C), these results
suggested that the activated GH signaling pathway, which
promoted protein synthesis and lipid catabolism, was facili-
tated via Insrb when insra was depleted. Strong evidence
suggests that insulin is required for the GH stimulation of
hepatic IGF-1 production. Insulin-dependent diabetes mellitus
is accompanied by GH resistance, with high GH levels in
serum but low circulating IGF-1 levels and poor growth (17,
50, 52). These results indicate that insulin is necessary for the
GH stimulation of IGF-1 production and growth. Animal
studies have demonstrated that insulin increases total GH
binding in the rat liver (3). However, the mechanisms involved
in this process have not been extensively studied. Our present
results provided more evidence for the positive regulatory
function of insulin/insrb on GH signaling in zebrafish (Fig. 5).
These findings support the results reported by Leung et al. (32),
who demonstrated that insulin increases GH signaling by
upregulating ghr mRNA abundance and total cellular content
of immunoreactive and functional receptors in HuH7 cells.
Interestingly, the genes involved in lipogenesis, i.e., fas,
fads2, elovl5, acc, and foxo1a, were uniformly downregulated
in insra/ fish (Fig. 6C), suggesting impaired lipogenesis in
insra/ fish. Combined with impaired glucose utilization,
we hypothesize that the transition from glucose to lipids may
be disrupted when insra is depleted. However, the downregu-
lation of genes involved in lipogenesis was not observed in
insrb/ fish, except for the key molecule that inhibits lipo-
genesis but promotes lipolysis, foxo1a (41). Meanwhile, com-
bined with the retention of fatty acids in the liver, whole body
and total lipids were significant higher in insrb/ fish (P 

0.05) than the other two groups. These results suggested that
lipid synthesis was promoted in insrb/ fish.
Fig. 7. Measurements of protein and lipid synthesis. A–C: measurement of the retention of radioactivity 2 h after intraperitoneal injection of L-[14 C(U)] amino
acid mixture in zebrafish of 3 genotypes to examine the level of protein synthesis in liver, muscle, and the whole body (n  5 for each genotype). D–G:
measurement of the retention of radioactivity 2 h after intraperitoneal injection of palmitic acid [1-14C] in zebrafish of 3 genotypes to examine the level of lipid
synthesis in visceral mass, the whole body, lipid, and muscle (n  5 for each genotype). The letters x, y, and z in the bar chart represent significant differences
of each index in insra/ fish, insrb/ fish and control fish (P 
 0.05). N. S., no significance.
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In our previous study, we performed RT-PCR of the two
receptors of insulin and observed similar expression patterns,
with both receptors abundantly expressed during early embry-
onic development and in tissues from adult fish (60). Uni-
formly, glucose levels increased in insra/ fish and in-
srb/ fish at both embryonic stage and adult stages, with
insra/ fish showing the highest level of glucose among the
three genotypes. These results indicate that Insra plays a more
important role in mediating glucose utilization. Combined with
the increased glucose level and decreased lipid content in
insra/ fish, we speculate that insulin promotes the transi-
tion from glucose to lipids via Insra, rather than Insrb, in both
liver and adipose tissues. Interestingly, the examination of key
elements involved in the insulin signaling pathway demon-
strated that these genes were largely unaffected in insra/
fish compared with control fish. Together with overactivated
GH signaling (increased shc, socs1a, socs2, igf1, and igf1r),
these results suggest that Insrb mediates GH to regulate IGF-
1/IGF-R signaling to compensate for the lack of insulin/insra
signaling (10). It has been reported that receptors with intra-
cellular domains of IGF1R show increased activation of Shc
and Gab-1 and more potent regulation of genes involved in
proliferation, corresponding to their higher mitogenic activity.
Meanwhile, receptors with the intracellular domain of Insr
display higher IRS-1 phosphorylation, stronger regulation of
genes in metabolic pathways, and more dramatic glycolytic
responses to hormonal stimulation (5). This may account for
the increased GH/IGF-1 signaling and protein synthesis in
insra/ fish.
After the discovery of the duplicated insr genes, insra and
insrb (54, 60), subsequent work has mainly focused on embry-
onic development. Although it is interesting to speculate
whether insr isoforms may have different physiological roles,
the effects on metabolism have not been well studied due to the
lack of effective models. However, this situation is changing
with the genetic editing approaches of TALEN and CRISPR/
Cas9 (13, 19). Utilizing our recent insra/ and insrb/
models, we are able to investigate the precise functions of Insra
and Insrb on zebrafish nutrient metabolism and somatic
growth. Dysfunction of insulin receptors and components of
the downstream signaling cascade results in insulin resistance,
which leads to type 2 diabetes mellitus. Mutations in insulin
receptors can result in many syndromes, such as leprechaunism
and Rabson-Mendenhall syndrome. Uniformly, patients with
these syndromes demonstrate severe insulin resistance (53).
Although clinical data indicate that insulin receptors are essen-
tial for development and metabolism, the mechanisms involved
in nutrient metabolism, which could provide evidence for the
treatment of these syndromes, are less defined. Thus, in utiliz-
ing the insra and insrb knockout zebrafish with a high-carbo-
hydrate diet as the model, this study provides a system to
understand the physiological roles of Insra or Insrb. Using this
system, we show that both Insra and Insrb play important
roles in maintaining the transduction of insulin signaling
and glycolysis, but Insra mainly promotes the transition
from glucose to lipids, whereas Insrb acts to promote lipid
catabolism and protein synthesis by enhancing the GH
signaling pathway (Fig. 8).
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